Panagora Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Panagora Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$317K	Buy	+132,042	New	+$257K	﹤0.01%	1019
2022 Q2	–	Sell	-53,152	Closed	-$111K	–	1546
2022 Q1	$111K	Sell	53,152 -236,327	-82%	-$655K	﹤0.01%	1497
2021 Q4	$1.14M	Buy	289,479 +325	+0.1%	+$1.58K	0.01%	861
2021 Q3	$1.39M	Buy	289,154 +15,420	+6%	+$63.3K	0.01%	820
2021 Q2	$1.26M	Buy	273,734 +101,861	+59%	+$491K	0.01%	893
2021 Q1	$1.01M	Buy	171,873 +7,822	+5%	+$54.2K	0.01%	1018
2020 Q4	$561K	Buy	164,051 +474	+0.3%	+$904	﹤0.01%	1183
2020 Q3	$236K	Buy	163,577 +108,574	+197%	+$193K	﹤0.01%	1446
2020 Q2	$110K	Sell	55,003 -75,119	-58%	-$147K	﹤0.01%	1754
2020 Q1	$254K	Buy	+130,122	New	+$387K	﹤0.01%	1381
2013 Q4	–	Sell	-629	Closed	-$10K	–	2219
2013 Q3	$10K	Hold	629	–	–	﹤0.01%	2256
2013 Q2	$10K	Buy	+629	New	+$9.56K	﹤0.01%	2247

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Panagora Asset Management's LXRX Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2026: 132,042 shares worth $317K. The stake represents ﹤0.01% of the portfolio and ranks #1019 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in LXRX as recently as Q1 2022.

Panagora Asset Management first reported a position in LXRX in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.39M in Q3 2021. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

Panagora Asset Management held 132,042 shares of Lexicon Pharmaceuticals worth $317K as of Q2 2026.
Lexicon Pharmaceuticals was a new Panagora Asset Management position in Q2 2026.
Lexicon Pharmaceuticals made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #1019 holding.
Panagora Asset Management first reported a position in Lexicon Pharmaceuticals in Q2 2013 and has held it in 12 quarters since.
Panagora Asset Management's Lexicon Pharmaceuticals position peaked at $1.39M in Q3 2021.
149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.